Financials in USD. Standardized financial statements.
A compact view of how Marinus Pharmaceuticals, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $30.99M | $25.48M | $15.35M | $1.72M | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +21.6% | +66.0% | +793.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1.93M | $340,000 | $1.48M | $50.51M | $503,000 | $127,000 | $126,000 | $23,000 | $11,000 | $0 |
| Gross Profit? | $29.05M | $25.14M | $13.87M | -$48.79M | -$503,000 | -$127,000 | -$126,000 | -$23,000 | -$11,000 | $0 |
| Gross Margin? | +93.8% | +98.7% | +90.4% | -2839.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $160.54M | $137.93M | $110.80M | $69.66M | $54.42M | $37.18M | $19.04M | $28.24M | $24.43M | $11.92M |
| Operating Income? | -$131.49M | -$112.79M | -$96.93M | -$67.94M | -$54.42M | -$37.18M | -$19.04M | -$28.24M | -$24.43M | -$11.92M |
| EBITDA? | -$125.50M | -$5.09M | -$95.53M | -$66.88M | -$53.92M | -$36.60M | -$18.61M | -$28.16M | -$24.36M | -$10.71M |
| Income Before Tax | -$142.94M | -$16.43M | -$98.78M | -$67.47M | -$54.12M | -$36.73M | -$18.90M | -$28.64M | -$24.85M | -$10.83M |
| Income Tax Expense | -$1.54M | $3.39M | $0 | $0 | $0 | $0 | $13,000 | $0 | $0 | $0 |
| Net Income? | -$141.41M | -$19.82M | -$101.66M | -$66.64M | -$53.77M | -$36.73M | -$18.90M | -$28.64M | -$24.85M | -$10.83M |
| EPS? | $-2.63 | $-0.51 | $-2.77 | $-2.44 | $-3.95 | $-3.59 | $-3.21 | $-5.88 | $-6.66 | $-7.04 |
| Diluted EPS? | $-2.63 | $-0.51 | $-2.77 | $-2.44 | $-3.95 | $-3.59 | $-3.21 | $-5.88 | $-6.66 | $-7.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality